Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hepatitis C

Enhancing treatment for hepatitis C among drug users

Nature Reviews Gastroenterology & Hepatology volume 8, pages 11–13 (2011)Cite this article

Subjects

Assessment and uptake of hepatitis C treatment among injection drug users with HCV infection remains low, partly due to concerns regarding poor adherence and response to therapy. Findings from a large, prospective study demonstrate comparable adherence and response to hepatitis C treatment among nondrug users, former drug users and active drug users.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Shepard, C. W., Finelli, L. & Alter, M. J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558–567 (2005).

    Article  PubMed  Google Scholar 

  2. Manns, M. P., Wedemeyer, H. & Cornberg, M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55, 1350–1359 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. NIH. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26, 2S–10S (1997).

  4. Sylvestre, D. L. Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug Alcohol Depend. 67, 117–123 (2002).

    Article  PubMed  Google Scholar 

  5. Backmund, M., Meyer, K., Von Zielonka, M. & Eichenlaub, D. Treatment of hepatitis C infection in injection drug users. Hepatology 34, 188–193 (2001).

    Article  CAS  PubMed  Google Scholar 

  6. NIH. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens. State Sci. Statements 19, 1–46 (2002).

  7. Grebely, J., deVlaming, S., Duncan, F., Viljoen, M. & Conway, B. Current approaches to HCV infection in current and former injection drug users. J. Addict. Dis. 27, 25–35 (2008).

    Article  PubMed  Google Scholar 

  8. Melin, P. et al. Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study. Eur. J. Gastroenterol. Hepatol. 22, 1050–1057 (2010).

    Article  CAS  PubMed  Google Scholar 

  9. Hellard, M., Sacks-Davis, R. & Gold, J. Hepatitis C treatment for injection drug users: a review of the available evidence. Clin. Infect. Dis. 49, 561–573 (2009).

    Article  PubMed  Google Scholar 

  10. Grebely, J. et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend. 93, 141–147 (2008).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Viral Hepatitis Clinical Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Ground Floor, CFI Building, Corner Boundary & West Streets, Darlinghurst, Sydney, NSW, Australia

    Jason Grebely & Gregory J. Dore

Authors
  1. Jason Grebely
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory J. Dore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory J. Dore.

Ethics declarations

Competing interests

G. Dore has received research support, is on the speaker's bureau and is a member of an advisory board for Roche Pharmaceuticals. He is also a Consultant/Advisor for Abbott, Merck, and Tibotec. J. Grebely is a member of an advisory board for Schering-Plough.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grebely, J., Dore, G. Enhancing treatment for hepatitis C among drug users. Nat Rev Gastroenterol Hepatol 8, 11–13 (2011). https://doi.org/10.1038/nrgastro.2010.186

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2010.186

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing